DOWNLOAD THE BOOK OF ABSTRACTS

Abstract Guidelines

All abstracts must be submitted electronically through the Congress abstract submission website where you will need to create an account that will also be used to register and book your accommodation.

• Abstracts will be accepted in English only
• There is no fee for submitting an abstract
• There are no limitations on the number of abstracts that an individual can submit. However, one individual can present a maximum of 3 abstract as oral presentations during the entire Congress. If you have more than 3 orals accepted, you will be obliged to identify alternate presenters for any abstract above the first three.
• The abstract text body is limited to 2,500 characters (Approx. 400 words) including spaces. A maximum of two figures/images (in JPG, GIF, or PNG with ideally 600 dpi) can be included. These will not count toward the word limit, nor will the information about authors, institutions and study groups. File size of 2 MB maximum for each figure.
• Tables: do not insert tables into the body of the abstracts, the system will not recognize the format of the table. Tables will need to be uploaded as image into the body of the abstract.
• Abstracts accepted for presentation will be published electronically in Transplantation, the official journal of The Transplantation Society. Abstracts not accepted for presentation or if the presenter is not officially registered to the Congress by the March 22^nd deadline will not be published. Abstracts will also be posted prior to the Congress on the detailed program of the Congress website.
• Employees of Commercial Entities: CIRTA recognizes that employees of commercial entities are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. Employees of commercial entities should submit abstracts when the content is limited to basic science research (e.g., pre-clinical research, drug discovery) or the processes/methodologies of research, themselves unrelated to a specific disease or compound/drug, and the abstract is not related to clinical applications of the research/discovery or clinical recommendations concerning the business lines or products of their employer.
• Disclosure: abstract submitter and presenter are required to disclose any conflict of interest
• Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after January 27, 2017. Once the abstract has been scored by reviewers, no change in the body of the abstract will be accepted.
• To be eligible to submit an abstract, you must disclose that the authors/ scientists have not violated any aspect of The Transplantation Society Ethics statements and that this research conforms with the ethical statements noted.

Policies for abstract submission

Copyright Policy
Abstracts should not include libelous or defamatory content. Material presented in abstracts should not violate any copyright laws. If figures/graphics/images have been taken from sources not copyrighted by the author, it is the author’s sole responsibility to secure the rights from the copyright holder in writing to reproduce those figures/graphics/images for both worldwide print and web publication. All reproduction costs charged by the copyright holder must be borne by the author.

Resubmission Policy
CIRTA welcomes the submission of abstracts that have been presented previously at regional, national, or international meetings in the two years since the last CIRTA 2017 meeting in New York City, given the highly specialized nature of the related topics.

Ethics Compliance
To be eligible to submit an abstract, you must disclose that the authors/ scientists have not violated any aspect of The Transplantation Society Ethics statements and that this research conforms with the ethical statements noted.

Scientific studies and clinical activities should be performed in keeping with the ethical principles delineated in the following policy documents:

• the Declaration of Istanbul (DOI) ethics’ statement
• the ethical statement on human research subject, Helsinki Declaration of The World Medical Association.
• the International Xenotransplantation Association Ethics Committee Position Paper on The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003) For research involving human subjects -The Helsinki.
• Institutional Ethical Review for human and/or animal research as appropriate

Abstract review and selection process

Abstract Review

• All submitted abstracts will go through a blinded peer-review process carried out by an international review committee.
• All abstracts will be reviewed (blinded) by at least three international referees, selected by the organizing committee.
• Abstracts which do not meet the focus of the topic category as requested by the authors will be reassigned to other category.
• Scores assigned by all reviewers are averaged. The cut-off average score for acceptance is based on available oral and poster presentations. Rejections are further evaluated by the scientific program committee.
• Poster and oral presentations are viewed as equally important components of the CIRTA 2019 Congress.

Format of presentation
You may opt to submit your abstract to be considered for an oral presentation, a poster presentation, or either (at the committee’s discretion).

Notification of Acceptance or Rejection to Corresponding Author
Notification of acceptance or rejection will be sent to the submitting (corresponding) author by March 8, 2019. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

Rule of Three
Each presenting author may present a maximum of three abstracts as orals at the congress. The number of submissions is however not limited. Should an author have more than three abstracts accepted for presentation, a co-author must be named as presenting author for one or more abstracts.